[Mailutils-i18n] These Stocks Can make You Money

[Trudy Messer]

Martin Nutraceuticals, Inc.(OTC: MTNU)
A Family of Nutraceuticals Developed to Enhance the Pleasure of Life and
Lifestyle. (Source: Company Website)

Current Price: 0.085

Will This One Explode Higher From Here? If you Think So, You May Want to
Take Action At The Open Tomorrow...

INVESTMENT HIGHLIGHTS: (Source: Recent News Releases)

A)Martin Nutraceuticals Announces Product Launch for Quebec- Established
July 15th, 2005 as the launch date for Martin products to be available in
the province of Quebec. The products being prepared are:

   1) Oxygenol(tm) - The world's most power antioxidant
      formula.  This will be available in liquid and capsules.

   2) Arithrizyme(tm)  - A systemic oral enzyme formula that
      helps to fight inflammatory conditions such as arthritis,
      sports injuries and Fibromyalgia.

   3) Maximum Slim(tm) - An all natur4l weight management
      formula that promotes healthy fat l0ss.

B)Martin Nutraceuticals Announces Clinical Trail Results for Weight L0ss and
Obesity Control With New Product- In this 4-week clinical trial, half the
patients were given 6 Maximum Slim(tm) capsules -- two with every meal, and
the other half were given a placebo. The group using Maximum Slim(tm) lost
an average of 3% body fat, while the placebo group averaged less than 0.5%
body fat.


C)Martin Nutraceuticals Inc. Announces Retail Expansion- Martin
Nutraceuticals Inc. is pleased to announce the completion of negotiations
that will place Martin products in retail outlets, chain stores and
warehouse distribution centers as soon as the end of the second quarter,
beginning of the third quarter.


ABOUT MTNU (Source: Company Website)

In 1989, The Foundation for Innovation in Medicine coined the term
"nutraceutical" to give identity to a highly promising area of health and
medicine.  Since then, the nutraceutical market has become a highly
respected industry for supplement health, averaging a 7% increase year over
year for the last 5 years.

Martin Nutraceuticals was a natural progression that started from the
inception of bettering the lifestyle of people.  Since, Martin
Nutraceuticals has created a family of complimentary medicine and
supplementation that has helped thousands of people suffering from arthritis
and general joint pain, poor circulation, tiredness, obesity and digestive
complications.


Please Watch This One Trade. These little stocks can surprise in a big way
sometimes....
                        _______________________________

Information within this email contains "forward looking statements" within
the meaning of Section 27A of the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs, plans,
projections, objectives, goals, assumptions or future events or performance
are not statements of historical fact and may be "forward looking
statements."Forward looking statements are based on expectations, estimates
and projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to differ
materially from those presently anticipated. Forward looking statements in
this action may be identified through the use of words such as "projects",
"foresee", "expects", "will," "anticipates," "estimates," "believes,"
"understands" or that by statements indicating certain actions "may,"
"could," or "might" occur. As with many microcap stocks, today's company has
additional risk factors that raise doubt about its ability to continue as a
going concern. Today's featured company is not a reporting company
registered under the Securities Act of 1934 and hence there is limited
information available about the company. Other factors include a limited
operating history,a nominal cash position, an accumulated deficit since its
inceptiion,a negative net worth and no revenues in its most recent
quarter. It is not currently an operating company. The company is going to
need financing. If that financing does not occur,the company  may not be
able to continue as a going concern in which case you could lose your entire
investment. Other risks and uncertainties include, but are not limited to,
the ability of the Company to complete its business plan,reliance on key
personnel, market conditions, the general acceptance of the Company's
products and technologies, competitive factors, timing, and other risks
associated with their business. The publisher of this newsletter does not
represent that the information contained in this message states all material
facts or does not omit a material fact necessary to make the statements
therein not misleading. All information provided within this email pertaining
to investing, stocks, securities must be understood as information provided
and not investment advice. The publisher of this newsletter advises all
readers and subscribers to seek advice from a register3d professional
securities representative before deciding to trade in stocks featured within
this email. None of the material within this report shall be construed as
any kind of investment advice or solicitation.Many of these companies are on
the verge of bankruptcy. You can lose all your money by investing in this
stock. The publisher of this newsletter is not a reg1stered investment
advis0r. Subscribers should not view information herein as legal, tax,
accounting or investment advice. Any reference to past performance(s) of
companies are specially selected to be referenced based on the favorable
performance of these companies. You would need perfect timing to acheive the
results in the examples given. There can be no assurance of that happening.
Remember, as always, past performance is never indicative of future results
and a thorough due diligence effort, including a review of a company's
filings when available, should be completed prior to investing. In
compliance with the Securities Act of 1933, Section17(b), The publisher of
this newsletter is contracted to  receive fifty thousand dollars from a
third party, not an officer, director or affiliate shareholder for the
circulation of this report. Be aware of an inherent conflict of interest
resulting from such compensation due to the fact that this is a paid
advertisement and is not without bias.The party that paid us has a position
in the stock they will sell at anytime without notice. This could have a
negative impact on the price of the stock, causing you to lose money. All
factual information in this report was gathered from public sources,
including but not limited to Company Websites, Information Statements and
Company Press Releases. The publisher of this newsletter believes this
information to be reliable but can make no guarantee as to its accuracy or
completeness. Use of the material within this email constitutes your
acceptance of these terms.